Pfizer/BioNTech COVID-19 vaccine – EUA granted for 6 months to 4 years
June 17, 2022 - The FDA announced the emergency use authorization (EUA) of the Pfizer/BioNTech COVID-19 vaccine for the prevention of COVID-19 to include use in children down to 6 months of age.
Download PDF
